Friday, January 11, 2008

Alfuzosin Hydrochloride for the Treatment of Benign Prostatic

Similar to other 1-adrenergic antagonists, alfuzosin is metabolized by the hepatic microsomal enzyme scheme.
Therefore, enzyme inhibitors and stimulators affect its metabolic process.
Both cimetidine and diltiazem slow hepatic metamorphosis of alfuzosin and step-up serum levels of diltiazem. Alfuzosin has been shown to reduce the bioavailability of oral diltiazem and movement hypotension when the collection is used.
The clinical value of these interactions has not been elucidated.

Alfuzosin does not appear to interact with warfarin, digoxin, hydrochlorothiazide, or atenolol. Care is recommended when alfuzosin is given to patients taking other antihypertensives (e.g., angiotensinconverting-enzyme inhibitors, -adrenergic antagonists, calcium-channel blockers) and ethanol.
This is because alfuzosin shares many of the pharmacologic effects of older 1-adrenergic antagonists.
Additive hypotensive effects have been previously reported with prazosin in accumulation with these drugs.
Therefore, if using alfuzosin in patients taking antihypertensives, the lowest effective dose of alfuzosin should be used.

Electrical phenomenon promotion labeling for viagra includes a judiciousness to avoid taking it within four period of an 1-adrenergic antagonists to avoid a systemic hypotensive response as a effect of the aggregation.
This is a part of article Alfuzosin Hydrochloride for the Treatment of Benign Prostatic Taken from "Sildenafil Soft Tab" Information Blog

No comments: